Substance / Medication

Thiabendazole

Overview

Active Ingredient
thiabendazole
RxNorm CUI
10450

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

6 trials linked to this intervention

6
Total Trials
2
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.
Henriquez-Camacho Cesar, Gotuzzo Eduardo, Echevarria Juan et al. · Cochrane Database Syst Rev · 2016
PMID: 26778150Meta-AnalysisFull text (PMC)
Strip-based immunoassay for rapid detection of thiabendazole.
Blazková Martina, Rauch Pavel, Fukal Ladislav · Biosens Bioelectron · 2010
PMID: 20236817Observational
Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents.
Muela Susana, Escalera Begoña, Peña M Angeles et al. · Int J Pharm · 2010
PMID: 19819314Observational
A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases.
Crocetti Letizia, Maresca Alfonso, Temperini Claudia et al. · Bioorg Med Chem Lett · 2009
PMID: 19186056Observational
Comparison of methods to detect resistance of Penicillium expansum to thiabendazole.
Cabañas R, Abarca M L, Bragulat M R et al. · Lett Appl Microbiol · 2009
PMID: 19196442Observational
Molecularly imprinted capillary electrochromatography for selective determination of thiabendazole in citrus samples.
Cacho Carmen, Schweitz Leif, Turiel Esther et al. · J Chromatogr A · 2008
PMID: 18154977Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tiabendazole (substance)
SNOMED CT
416624006
UMLS CUI
C0039832
RxNorm CUI
10450

Clinical Data

This intervention maps to 5 entities in the Healos knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
6
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.